dQ&A First Look – Awiqli
How will once-weekly basal insulin reshape diabetes care?
Once-weekly basal insulin is moving from clinical trials into the real world and raising a new set of questions for the diabetes industry.
- Will patients embrace weekly dosing?
- Is the value about more than just ‘fewer injections’?
- What happens to adherence, glucose monitoring and treatment burden?
- What could once-weekly insulin mean for the broader diabetes market?
share their Awiqli experiences.
Karen
Creative, Up-beat Moderator/Interviewer
"Insights I draw from our amazing panelists influence our client's smart decisions and directly improve life for very people I get to interview! How great is that?!”
Trevor
Mixed-Methods Research Expert. Multiple Published Papers.
"As someone with T1D, I'm grateful our work directly impacts devices and therapies”
Christianne
Data Services Architect. Career Research Guru.
“I have been working with dQ&A for over ten years, 100% focused on diabetes. I so love contributing to those mission-critical decisions.”
Phin
VP, Research Services. Structures big data to drive analysis and insight.
“It's a real privilege to work with data that can make such a significant difference”
Kim
10 Years on the Client Side. Delivers Actionable Insights
“At dQ&A I’m surrounded by seasoned researchers and compassionate individuals, united in our mission to make life better for people living with diabetes”
Phyllisa
Patient Advocate. Manages Content for People With Diabetes
“For the first time in my career, I don't deal with diabetes stigma in the workplace.”
dQ&A Has Answers
dQ&A First Look Awiqli provides some of the first real-world answers.
Drawing on qualitative interviews, quantitative research and real-world clinical data from Canadian patients already using Awiqli, the study offers an early view of how patients are adapting to a fundamentally different way of taking basal insulin.
Hear it directly from some of the first Awiqli users.
Whether you work in insulin, diabetes technology connected health or patient support, First Look Awiqli can help you understand how once-weekly insulin may change patient expectations, behaviors and needs.
Do You Have Questions
About Diabetes Research?
This research excerpt is just the tip of the iceberg. dQ&A has decades of experience across the United States, Canada, and Europe. If you drive critical diabetes research decisions in your organization, dQ&A is the diabetes insight partner that can get the answers you need.
